These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Introduction: defining remission in patients treated with antidepressants. Thase ME J Clin Psychiatry; 1999; 60 Suppl 22():3-6. PubMed ID: 10634348 [No Abstract] [Full Text] [Related]
4. Classification of neuroleptics based on their pharmacokinetics. Dahl SG Clin Neuropharmacol; 1986; 9 Suppl 4():409-11. PubMed ID: 2882845 [No Abstract] [Full Text] [Related]
5. Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz. Rickels K; Robinson DS J Clin Psychopharmacol; 2009 Apr; 29(2):197-8; author reply 198-9. PubMed ID: 19512995 [No Abstract] [Full Text] [Related]
6. Generalizability of antidepressant efficacy trials. Zimmerman M; Posternak MA; Chelminski I Essent Psychopharmacol; 2004; 6(1):45-58. PubMed ID: 15612653 [No Abstract] [Full Text] [Related]
7. Clinical evaluation of two new antidepressants. Gershon S; Georgotas A; Newton R; Bush D Adv Biochem Psychopharmacol; 1982; 32():57-68. PubMed ID: 6211943 [No Abstract] [Full Text] [Related]
8. [Effect of neuroleptics on depressive symptoms]. Tabeze JP Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254 [No Abstract] [Full Text] [Related]
9. Four new atypical antidepressants (trazodone, mianserin, nomifensine, caroxazone): results of controlled trials. Cassano GB; Conti L; Dell'Osso L; Massimetti G Adv Biochem Psychopharmacol; 1982; 32():125-39. PubMed ID: 7046361 [No Abstract] [Full Text] [Related]
10. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent]. Binz U; Wendt G Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074 [No Abstract] [Full Text] [Related]
11. The mousetrap: managing the placebo effect in antidepressant trials. Lakoff A Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352 [No Abstract] [Full Text] [Related]
12. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients. Diaz A; Fouilloux C; Ortiz S Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564 [No Abstract] [Full Text] [Related]
13. Rating rater improvement: a method for estimating increased effect size and reduction of clinical trial costs. Cogger KO J Clin Psychopharmacol; 2007 Aug; 27(4):418-20. PubMed ID: 17632240 [No Abstract] [Full Text] [Related]
14. Antidepressants and psychosis in Parkinson disease: a case series. Voon V; Fox S; Butler TR; Lang AE Int J Geriatr Psychiatry; 2007 Jun; 22(6):601-4. PubMed ID: 17450623 [No Abstract] [Full Text] [Related]
15. [Characteristics of the interaction of neuroleptics and antidepressants with plasma proteins (review of the literature)]. Bender KI; Kupchikov VV; Lutsevich AN Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):116-24. PubMed ID: 1686128 [No Abstract] [Full Text] [Related]
16. The treatment of psychotic depression. Coryell W J Clin Psychiatry; 1998; 59 Suppl 1():22-7; discussion 28-9. PubMed ID: 9448666 [TBL] [Abstract][Full Text] [Related]
17. Summary: defining remission in patients treated with antidepressants. Thase ME J Clin Psychiatry; 1999; 60 Suppl 22():35-6. PubMed ID: 10634354 [No Abstract] [Full Text] [Related]